$1.02
0.0222.2%
Last update: Oct 23, 7:31 PM
Stereotaxis Inc (STXS) Stock Price, Quote, News & History
STXSAMEX
Stereotaxis to acquire Robocath, advancing robotic endovascular tech and accelerating expansion into cardiology and neuro markets.
You can purchase shares of Stereotaxis (AMEX:STXS) through any online brokerage.
Other companies in Stereotaxis’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
Stereotaxis has a consensus price target of $3.75.
The stock price for Stereotaxis (AMEX: STXS) is $1.02 last updated October 23, 2026 at 7:31 PM EDT.
There are no upcoming dividends for Stereotaxis.
Stereotaxis does not have any upcoming earnings scheduled.
There is no upcoming split for Stereotaxis.
Stereotaxis is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the AMEX.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and...
